Kearns et al. [24] demonstrated that adiponectin levels, measured at three time points (0, 24, and 72 h of hospitalization), were significantly lower in patients with respiratory failure due to COVID-19 compared to those with respiratory failure associated with other infectious diseases. This evidence concerns the gene ADIPOQ and infectious disease.